ARCHIVES

New Compounds To Treat Gleevec-Resistant CML

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

Funding Opportunities: NCI Lists Initiatives, Web Links For Info, About Research On Prostate Cancer

December 11, 1998

Alternative Medicine Officer Awards 30 Research Grants

October 15, 1993

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

October 23, 1992